Moolec Science SA Dossier
Outlook & Key Dates
Estimates, guidance, catalysts, and upcoming events
Analyst Estimates Learn more →
FY EPS (est.)
-$0.24next fiscal year
Reporting Calendar
| Event | Expected Date |
|---|---|
| Fiscal Year 2026 Annual Business Update and Earnings Release | 2 Oct 2026 |
Monitoring Framework
Key Performance Indicators
GLASO Safflower Platform Gamma-Linolenic Acid (GLA) Concentration Annually4,500.0%Target: Maintain or exceed 45% GLA concentration at commercial scale
Stockholders' Equity Quarterly15.2MTarget: Maintain compliance with Nasdaq Capital Market minimum stockholders' equity requirement of $2.5 million
Watch Items
- Nasdaq Capital Market Continued Listing ComplianceTrigger: Stockholders' equity falling below $2.5 million or share price falling below $1.00Action: Implement capital-strengthening measures, such as converting remaining preference shares or executing reverse stock splits.
- Commercialization of GLASO1 Safflower PlatformTrigger: Delays in 2026 campaign harvest or failure to secure offtake agreements in pet food and human nutrition marketsAction: Optimize agronomic management, leverage agricultural infrastructure in Idaho, and expand strategic research collaborations.
Research as of 20 Jun 2026